ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
38 hedge funds and large institutions have $11.2M invested in Oncternal Therapeutics, Inc. Common Stock in 2015 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
47% less capital invested
Capital invested by funds: $21M → $11.2M (-$9.88M)
Holders
38
Holding in Top 10
–
Calls
$19K
Puts
$29K
Top Buyers
| 1 | +$129K | |
| 2 | +$97K | |
| 3 | +$71.3K | |
| 4 |
SIM
Spark Investment Management
New York
|
+$46K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$29K |
Top Sellers
| 1 | -$66K | |
| 2 | -$32.6K | |
| 3 | -$28K | |
| 4 |
OC
Oppenheimer & Co
New York
|
-$16K |
| 5 |
BRWM
B. Riley Wealth Management
Memphis,
Tennessee
|
-$13K |